21 Chemin de la Sauvegarde
69130 Ecully - FRANCE Site web

Key figures

Creation date: 2002
Number of employees: 2956
Investment date: 22/06/2016
Fund name: Mérieux Participations 2

Company presentation

Seqens is an integrated global leader in pharmaceutical synthesis and specialty ingredients, delivering unrivalled market responsiveness and tailor-made solutions to their customers. 

With 24 manufacturing sites and 3 R&D centers in Europe, North America and Asia, Seqens develops custom solutions and ingredients for the most demanding industries such as healthcare, electronics, cosmetics, food and homecare.  

Seqens is the new name for Novacap and all its activities as of December 2018.